Promomed

Russian Pharma Manufacturer Opens R&D Centre In China

Published on November 16, 2026

Russia’s Promomed, a leading innovative biopharmaceutical company that implements a full-cycle production model – is going to focus on joint research, molecule development, and clinical trials, and has established a Representative Office in Beijing, according to CEO Petr Bely.

He stated that “Russia has always been a source of intellectual solutions, while Moscow and Beijing have excellent opportunities in exchanging medicines. Promomed’s drugs are of interest to the Chinese, while Chinese drugs will be presented in Russia based on research.” He added that the initiative would support the exchange of pharmaceutical developments between Russia and China, bringing new treatments to doctors and patients in both countries, and that it will be responsible for ensuring the availability of medications for the treatment of socially significant diseases both in Russia and abroad. In addition, Promomed plans to develop partnerships with Chinese companies in the pharmaceutical industry. The work will focus on several strategic areas, from forming stable relationships with commercial organizations, manufacturers of high—tech equipment and specialized development companies to joint projects with scientific institutes. The cooperation will focus on expanding the evidence base of Promomed’s portfolio of drugs, obtaining new biologically active molecules, conducting large-scale clinical trials and introducing drugs into the global healthcare system. 

A ceremony was held at the Russian Trade Centre in Beijing to mark the occasion, with Trade Centre Representative Alexey Dakhnovsky saying that “In the first ten months of 2026, the mutual trade turnover between our countries increased by 32.1% compared to the same period last year and amounted to US$242.5 billion. This is almost the volume that was achieved in a whole year in the record year of 2024. Not only trade is developing, but also technological cooperation and industrial cooperation, including pharmaceutical and medical industries. In particular, in the field of technologies for the production of veterinary drugs and anti-oncological vaccines. The Russian Trade Mission in China provides maximum assistance to Russian and Chinese companies in finding reliable suppliers, establishing contacts, and supporting localization projects and joint production.”

Bely also said that Promomed are ready to supply Africa with medicines, calling export opportunities “interesting.”

Continue Reading